Gene · 9507
Papers2,479
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 2,479
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tougu Xiaotong capsules may inhibit p38 MAPK pathway-mediated inflammation: In vivo and in vitro verification. | J Ethnopharmacol | 2020 | 31760158 | PubTator, text mining | PubMed |
| ADAMTS4 and ADAMTS5 may be considered as new molecular therapeutic targets for cartilage damages with Kashin-Beck Disease. | Med Hypotheses | 2020 | 31734379 | PubTator, text mining | PubMed |
| Investigation of the STOX1 polymorphism on lumbar disc herniation. | Mol Genet Genomic Med | 2020 | 31724315 | PubTator, text mining | PubMed |
| GRK5 Inhibition Attenuates Cartilage Degradation via Decreased NF-κB Signaling. | Arthritis Rheumatol | 2020 | 31696655 | PubTator, text mining | PubMed |
| Extracellular matrix and biomimetic engineering microenvironment for neuronal differentiation. | Neural Regen Res | 2020 | 31638079 | PubTator, text mining | PubMed |
| Analysis of Aggrecanase Activity Using Neoepitope Antibodies. | Methods Mol Biol | 2020 | 31463908 | PubTator, text mining | PubMed |
| Chemical Modification of Proteoglycanases with Biotin. | Methods Mol Biol | 2020 | 31463907 | PubTator, text mining | PubMed |
| Purification and Activity Determination of ADAMTS-4 and ADAMTS-5 and Their Domain Deleted Mutants. | Methods Mol Biol | 2020 | 31463904 | PubTator, text mining | PubMed |
| Expression and role of Sphingosine 1-phosphate receptors in intervertebral disc degeneration. | J Back Musculoskelet Rehabil | 2020 | 31403937 | PubTator, text mining | PubMed |
| Interaction between Mesenchymal Stem Cells and Intervertebral Disc Microenvironment: From Cell Therapy to Tissue Engineering. | Stem Cells Int | 2019 | 32587618 | PubTator, text mining | PubMed |
| Restoration of Autophagic Flux Rescues Oxidative Damage and Mitochondrial Dysfunction to Protect against Intervertebral Disc Degeneration. | Oxid Med Cell Longev | 2019 | 31976028 | PubTator, text mining | PubMed |
| LincRNA-SLC20A1 (SLC20A1) promotes extracellular matrix degradation in nucleus pulposus cells in human intervertebral disc degeneration by targeting the miR-31-5p/MMP3 axis. | Int J Clin Exp Pathol | 2019 | 31934214 | PubTator, text mining | PubMed |
| MicroRNA-497-5p attenuates IL-1β-induced cartilage matrix degradation in chondrocytes via Wnt/β-catenin signal pathway. | Int J Clin Exp Pathol | 2019 | 31934153 | PubTator, text mining | PubMed |
| Naringin Protects Against Interleukin 1β (IL-1β)-Induced Human Nucleus Pulposus Cells Degeneration via Downregulation Nuclear Factor kappa B (NF-κB) Pathway and p53 Expression. | Med Sci Monit | 2019 | 31927560 | PubTator, text mining | PubMed |
| Extracellular Matrix Composition and Remodeling: Current Perspectives on Secondary Palate Formation, Cleft Lip/Palate, and Palatal Reconstruction. | Front Cell Dev Biol | 2019 | 31921852 | PubTator, text mining | PubMed |
| Fibromodulin - A New Target of Osteoarthritis Management? | Front Pharmacol | 2019 | 31920661 | PubTator, text mining | PubMed |
| Melatonin Prevents Osteoarthritis-Induced Cartilage Degradation via Targeting MicroRNA-140. | Oxid Med Cell Longev | 2019 | 31915516 | PubTator, text mining | PubMed |
| Proteomics analysis of colon cancer progression. | Clin Proteomics | 2019 | 31889941 | PubTator, text mining | PubMed |
| Profile of Matrix-Remodeling Proteinases in Osteoarthritis: Impact of Fibronectin. | Cells | 2019 | 31877874 | PubTator, text mining | PubMed |
| Extracellular matrix, regional heterogeneity of the aorta, and aortic aneurysm. | Exp Mol Med | 2019 | 31857579 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9507/papers?page=59